Paradigm Biocapital Advisors’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Other funds holding ASMB
SFCM
Paradigm Biocapital Advisors's ASMB Position: Q3 2026 in Review
Paradigm Biocapital Advisors held its Assembly Biosciences (ASMB) position steady in Q3 2026 at 1,553,748 shares worth $36.5M. The position accounts for 0.73% of the portfolio, ranked #22.
Paradigm Biocapital Advisors first reported a position in ASMB in Q4 2025 and has held it in 4 quarters since. The position peaked at $42.7M in Q2 2026. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.
- Paradigm Biocapital Advisors held 1,553,748 shares of Assembly Biosciences worth $36.5M as of Q3 2026.
- Paradigm Biocapital Advisors left its Assembly Biosciences share count unchanged in Q3 2026.
- Assembly Biosciences made up 0.73% of Paradigm Biocapital Advisors's portfolio in Q3 2026, its #22 holding.
- Paradigm Biocapital Advisors first reported a position in Assembly Biosciences in Q4 2025 and has held it in 4 quarters since.
- Paradigm Biocapital Advisors's Assembly Biosciences position peaked at $42.7M in Q2 2026.
- 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.
Based on Paradigm Biocapital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.